Literature DB >> 16837084

Autoimmunity in myocardial infarction.

Yu-Hua Liao1, Xiang Cheng.   

Abstract

Myocardial infarction is associated with an immune response. Physiological inflammation response causes self-repair and protection, while pathological autoimmune response leads to ventricular remodeling and heart failure. Laying emphasis on regulating the immune function may become a new target for the prevention of heart failure after myocardial infarction. This review focuses on the mechanism of immune-mediated ventricular remodeling and the immune therapy after myocardial infarction.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16837084     DOI： 10.1016/j.ijcard.2006.05.009

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  11 in total

1.  Infection, Oxidative Stress, and Changes in Circulating Regulatory T Cells of Heart Failure Patients Supported by Continuous-Flow Ventricular Assist Devices.

Authors:  Nandan K Mondal; Michael A Sobieski; Si M Pham; Bartley P Griffith; Steven C Koenig; Mark S Slaughter; Zhongjun J Wu
Journal:  ASAIO J       Date:  2017 Mar/Apr       Impact factor: 2.872

2.  Reperfusion injury intensifies the adaptive human T cell alloresponse in a human-mouse chimeric artery model.

Authors:  Tai Yi; Birgit Fogal; Zhengrong Hao; Zuzana Tobiasova; Chen Wang; Deepak A Rao; Rafia S Al-Lamki; Nancy C Kirkiles-Smith; Sanjay Kulkarni; John R Bradley; Alfred L M Bothwell; William C Sessa; George Tellides; Jordan S Pober
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-03       Impact factor: 8.311

3.  Myeloid interleukin-4 receptor α is essential in postmyocardial infarction healing by regulating inflammation and fibrotic remodeling.

Authors:  Jianrui Song; Ryan A Frieler; Steven E Whitesall; Yutein Chung; Thomas M Vigil; Lindsey A Muir; Jun Ma; Frank Brombacher; Sascha N Goonewardena; Carey N Lumeng; Daniel R Goldstein; Richard M Mortensen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-11-08       Impact factor: 4.733

4.  Cardiac biomarkers in the intensive care unit.

Authors:  Anthony S McLean; Stephen J Huang
Journal:  Ann Intensive Care       Date:  2012-03-07       Impact factor: 6.925

5.  Cost-effectiveness of cardiac biomarkers as screening test in acute chest pain.

Authors:  Samad Shams-Vahdati; Zahra Vand-Rajavpour; Seyed-Pouya Paknezhad; Reza Piri; Elnaz Moghaddasi-Ghezeljeh; Saba Mirabolfathi; Mohammad Naghavi-Behzad
Journal:  J Cardiovasc Thorac Res       Date:  2014-03-21

6.  Activation of CD4 and CD8 T cell receptors and regulatory T cells in response to human proteins.

Authors:  Borros M Arneth
Journal:  PeerJ       Date:  2018-03-09       Impact factor: 2.984

Review 7.  Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction.

Authors:  Irina Kologrivova; Marina Shtatolkina; Tatiana Suslova; Vyacheslav Ryabov
Journal:  Front Immunol       Date:  2021-04-02       Impact factor: 7.561

8.  Emergence of dendritic cells in the myocardium after acute myocardial infarction - implications for inflammatory myocardial damage.

Authors:  Atilla Yilmaz; Barbara Dietel; Iwona Cicha; Katja Schubert; Roland Hausmann; Werner G Daniel; Christoph D Garlichs; Christian Stumpf
Journal:  Int J Biomed Sci       Date:  2010-03

9.  T-cells in myocardial infarction: Culprit instigators or mere effectors?

Authors:  Luca Liberale; Aldo Bonaventura; Fabrizio Montecucco
Journal:  World J Cardiol       Date:  2018-10-26

Review 10.  Therapeutic implications of ongoing alveolar viral replication in COVID-19.

Authors:  Dennis McGonagle; Mary F Kearney; Anthony O'Regan; James S O'Donnell; Luca Quartuccio; Abdulla Watad; Charles Bridgewood
Journal:  Lancet Rheumatol       Date:  2021-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.